Submit Content Become a member
Colin Hay

Wellnex Life's (ASXL: WNX) plans to expand into the United Kingdom has been boosted by the receipt of its opening purchase order from Haleon for the Paracetamol Soft Gel Liquid Analgesic.

 

The company has received the first Purchase Order for TGA registered paracetamol soft gel liquid analgesic for the UK market. The expansion into the UK market builds on the launch of the Australian market which commenced in FY23 and the imminent launch into the United Arab Emirates.

 

Wellnex supplies one of the world’s largest independent consumer healthcare companies Haleon with this innovative product for use in one of the world’s most trusted pain relief brands - Panadol.

 

According to Wellness, the arrangement with Haleon is a testament and validation of Wellnex’s business model of being the owner of healthcare brands and IP for the Australian and global markets.

 

Wellnex Life announced in late June 2023 that it had agreed to extend the supply agreement with Haleon by increasing the product offerings and territories to take advantage of the unique and innovative TGA approved products.

 

This builds on the successful launch in Australia where Wellnex Life has been supplying product to Haleon for one of the worlds most trusted pain relief brands - Panadol.

 

Haleon is a world-leading consumer healthcare company that owns brands including Panadol, Sensodyne, Voltaren, Polident, Centrum, Otrivin and Advil.

 

This significant step in the launch of an important market in the UK and working with one of world’s largest consumer healthcare companies highlights the benefits of Wellnex’s business model of identifying innovative healthcare products enabling Wellnex to secure valuable agreements with leading partners, such as Haleon.

 

“The launch with Haleon for the UK market for our TGA registered paracetamol soft gel liquid analgesic for one of Europe’s largest markets is an important milestone for the company,” Zack Bozinovski, Director of Wellnex, said.

 

“The trust and confidence imparted upon Wellnex to supply one of the world’s leading pain relief brands in Panadol is a validation and testament to our Wellnex Life’s business model.”

Rate article from Colin Hay: